In addition to FGL-1 and fetuin-A, numerous studies have demonstrated that CT-1 plays a role in NAFLD, and it exerts beneficial effects on organ protection, including the liver. This evidence concerns the gene FGL1 and metabolic dysfunction-associated steatotic liver disease.